These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32554470)

  • 21. VISTA: Coming of age as a multi-lineage immune checkpoint.
    ElTanbouly MA; Schaafsma E; Noelle RJ; Lines JL
    Clin Exp Immunol; 2020 May; 200(2):120-130. PubMed ID: 31930484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
    Böger C; Behrens HM; Krüger S; Röcken C
    Oncoimmunology; 2017; 6(4):e1293215. PubMed ID: 28507801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the V-Type Immunoglobulin Domain-Containing Suppressor to T Cell Activation (VISTA) with Agonist Monoclonal Antibodies in Autoimmunity.
    Jung M; Bonavida B
    Crit Rev Immunol; 2022; 42(4):37-49. PubMed ID: 37022358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
    Noelle RJ; Lines JL; Lewis LD; Martell RE; Guillaudeux T; Lee SW; Mahoney KM; Vesely MD; Boyd-Kirkup J; Nambiar DK; Scott AM
    Front Oncol; 2023; 13():1225081. PubMed ID: 37795437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.
    Kondo Y; Ohno T; Nishii N; Harada K; Yagita H; Azuma M
    Oral Oncol; 2016 Jun; 57():54-60. PubMed ID: 27208845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy Resistance in Neoadjuvantly Treated Gastric Cancer and Cancer of the Gastroesophageal Junction is Associated with an Increased Expression of Immune Checkpoint Inhibitors-Comparison Against a Therapy Naïve Cohort.
    Schoop H; Bregenzer A; Halske C; Behrens HM; Krüger S; Egberts JH; Röcken C
    Transl Oncol; 2020 Feb; 13(2):165-176. PubMed ID: 31865179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Clinical Approaches and Emerging Evidence on Immune-Checkpoint Inhibitors as Anti-Cancer Therapeutics: CTLA-4 and PD-1 Pathways and Beyond.
    Christodoulou MI; Zaravinos A
    Crit Rev Immunol; 2019; 39(5):379-408. PubMed ID: 32422018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress on tumor immune checkpoints and their inhibitors in tumor therapy].
    Wang L; Bai L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):663-670. PubMed ID: 34140079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nature and Significance of Stromal Differentiation, PD-L1, and VISTA in GIST.
    Hacking S; Wu D; Lee L; Vitkovski T; Nasim M
    Pathol Res Pract; 2022 Jan; 229():153703. PubMed ID: 34929600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy.
    Chowdhury PS; Chamoto K; Honjo T
    J Intern Med; 2018 Feb; 283(2):110-120. PubMed ID: 29071761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.
    Huang X; Zhang X; Li E; Zhang G; Wang X; Tang T; Bai X; Liang T
    J Hematol Oncol; 2020 Jun; 13(1):83. PubMed ID: 32600443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
    Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
    Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors.
    Chmiel P; Gęca K; Michalski A; Kłosińska M; Kaczyńska A; Polkowski WP; Pelc Z; Skórzewska M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
    Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J
    Front Immunol; 2020; 11():563044. PubMed ID: 33250890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Benzo[
    Wang K; Cai S; Cheng Y; Qi Z; Ni X; Zhang K; Xiao Y; Zhang X; Wang T
    J Med Chem; 2024 Oct; 67(20):18526-18548. PubMed ID: 39389791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
    Albertsmeier M; Altendorf-Hofmann A; Lindner LH; Issels RD; Kampmann E; Dürr HR; Angele MK; Klauschen F; Werner J; Jungbluth AA; Knösel T
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging targets in cancer immunotherapy.
    Burugu S; Dancsok AR; Nielsen TO
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):39-52. PubMed ID: 28987965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA).
    Wang T; Wang K; Zhang Y; Zhang K; Cai S; Jiang S; Xiao Y; Zhang X
    J Med Chem; 2023 Sep; 66(17):11881-11892. PubMed ID: 37594853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations.
    Jiang Y; Chen M; Nie H; Yuan Y
    Hum Vaccin Immunother; 2019; 15(5):1111-1122. PubMed ID: 30888929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.